<DOC>
	<DOC>NCT02077946</DOC>
	<brief_summary>This trial is conducted in Europe. The aim of this study is to investigate a retrospective database assessment of clinical effectiveness in type 2 diabetes patients treated with liraglutide from primary care centers in Sweden.</brief_summary>
	<brief_title>A Retrospective Database Assessment of Clinical Effectiveness in Type 2 Diabetes Patients Treated With Liraglutide From Primary Care Centers in Sweden</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Patients from EMR (electronic medical record) system in the primary care in Sweden Patients equal to or more than 18 years of age Starting treatment with liraglutide or sitagliptin from January 2010 to December 2013 Minimum of 180 days of prior followup/history within the database before their index date Patients with cancer, end stage liver disease, end stage renal failure (nondiabetes related) Female patients with gestational diabetes during pregnancy Patients with previous GLP1 (glucagonlike peptide1) or DPPIV (dipeptidyl peptidase4 ) inhibitor use, i.e. patients should be incretin na√Øve</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>